Ares Genetics GmbH is a Vienna based developer of next-generation solutions for infectious disease diagnostics and therapeutics and was founded in Spring 2017 as a wholly owned subsidiary of Curetis GmbH. Ares Genetics leverages ARES Technology Platform which combines the world’s most comprehensive database on the genetics of antimicrobial resistance with advanced bioinformatics and artificial intelligence.
R&D:Rapidly spreading antibiotic resistance of bacterial pathogens has become a severe global health threat and is projected to claim more than 10 million annual casualties by 2050. Leveraging ARES Technology Platform, Ares Genetics develops and commercializes the next generation of data-driven solutions to become a leading provider of advanced products and services in the field of molecular microbiology.
Services:Ares Genetics leverages ARES Technology Platform and its broad IP Portfolio to provide rapid and easy to use sample to answer solutions for surveillance, diagnosis and therapy of microbial infections. In addition, Ares Genetics provides data-driven support for pharmaceutical companies to accelerate antimicrobial drug development.
Karl-Farkas-Gasse 18
1030 Vienna
Vienna
Contact: Andreas Posch (Managing Director)
Telephone: +43 (1) 361-8880
Email: contact@ares-genetics.com
Website